The efficacy of remdesivir in reducing SARS-CoV-2 viral load and its safety on COVID-19 patients: a systematic review
Jurnal Respirologi Indonesia
; 42(1):76-85, 2022.
Article
in English
| CAB Abstracts | ID: covidwho-1994966
ABSTRACT
Background:
This study aimed to examine the effectiveness of Remdesivir in reducing Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) viral load and its safety for antiviral therapy in Coronavirus disease 2019 (COVID-19) treatment.
Pesticides and Drugs; Control [HH405]; Prion, Viral, Bacterial and Fungal Pathogens of Humans [VV210]; Non-communicable Human Diseases and Injuries [VV600]; Non-drug Therapy and Prophylaxis of Humans [VV710]; antiviral agents; coronavirus disease 2019; drug therapy; efficacy; guidelines; haemodialysis; hepatotoxins; human diseases; liver; meta-analysis; pandemics; patients; randomized controlled trials; remdesivir; respiratory system; safety; symptoms; systematic reviews; toxicity; transplantation; viral diseases; viral load; man; Severe acute respiratory syndrome coronavirus 2; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; antivirals; chemotherapy; recommendations; hemodialysis; SARS-CoV-2; viral infections
Full text:
Available
Collection:
Databases of international organizations
Database:
CAB Abstracts
Type of study:
Reviews
/
Systematic review/Meta Analysis
Language:
English
Journal:
Jurnal Respirologi Indonesia
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS